Recall of Philips Respironics Trilogy Evo O2 Ventilator for Safety Issue
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Philips Respironics is recalling 113,717 units of its Trilogy Evo O2 ventilator due to potential discrepancies in tidal volume when using non-pneumatic nebulizers.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 8, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
Recall Article: Philips Respironics Trilogy Evo O2
What Happened
Philips Respironics, Inc. is initiating a voluntary recall of its Trilogy Evo O2 ventilator devices because using non-pneumatic nebulizers may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.
Which Products Are Affected
The affected products are the Philips Respironics Trilogy Evo O2 with Software Version 1.05.15.00. This includes all model numbers, all UDIs, and all serial numbers. A total of 113,717 units are affected, with distribution nationwide in the United States and to various international countries.
What You Should Do
Consumers who have received a letter from the firm should follow the instructions provided as part of this voluntary recall.
Why This Matters
This recall is significant because the discrepancy could impact patient safety for those using the ventilator for breathing support, potentially leading to health risks.
Source
This information is from the FDA, recall number Z-1615-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,050 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to April 8, 2026.
Frequently Asked Questions
Common questions about this FDA recall.